Due to our findings of RECK/EMMPRIN imbalance in urothelial bladder carcinoma [6], which could promote invasion processes, we decided to look not only at RECK, but also at the EMMPRIN counterpart in renal cell carcinoma. This evidence concerns the gene RECK and bladder transitional cell carcinoma.